GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
K

Kontour XiAn Medical Technology Co 688314.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

26.14

-0.42%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥349.6m

FY2017FY2025

Net income

CN¥98.8m

FY2017FY2025

Free cash flow

CN¥66.7m

FY2017FY2025

Shareholders' equity

CN¥717.8m

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueCN¥349.6mCN¥321.9mCN¥275.0mCN¥239.9mCN¥212.5mCN¥164.1mCN¥147.8mCN¥109.5mCN¥72.5m
Research and developmentCN¥25.6mCN¥23.9mCN¥17.6mCN¥18.3mCN¥16.8mCN¥16.9mCN¥10.6mCN¥8.1mCN¥4.4m
Operating incomeCN¥115.8mCN¥105.7mCN¥91.4mCN¥86.3mCN¥86.3mCN¥51.8mCN¥60.2mCN¥23.4mCN¥11.6m
Net incomeCN¥98.8mCN¥88.4mCN¥75.5mCN¥75.7mCN¥81.6mCN¥52.4mCN¥51.9mCN¥22.2mCN¥10.1m
Diluted earnings per share1.251.110.940.921.000.860.660.280.13

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsCN¥909.2mCN¥747.2mCN¥675.8mCN¥638.1mCN¥573.4mCN¥291.5mCN¥228.3mCN¥155.5mCN¥128.6m
Cash and short-term investments—CN¥378.5mCN¥375.1mCN¥349.2mCN¥325.3mCN¥92.8mCN¥112.0mCN¥20.6mCN¥40.2m
Total liabilitiesCN¥185.1mCN¥109.4mCN¥84.3mCN¥96.5mCN¥72.0mCN¥48.5mCN¥35.8mCN¥28.3mCN¥26.7m
DebtCN¥33.9mCN¥44.9mCN¥39.0mCN¥38.9mCN¥23.0mCN¥14.1mCN¥8.1mCN¥4.0mCN¥136,186
Shareholders' equityCN¥717.8mCN¥635.6mCN¥587.2mCN¥543.3mCN¥503.3mCN¥244.5mCN¥192.7mCN¥126.2mCN¥100.0m
Shares outstanding79m80m80m82m81m61m79m79m79m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsCN¥118.0mCN¥140.3mCN¥88.5mCN¥92.0mCN¥103.3mCN¥57.8mCN¥57.8mCN¥22.8mCN¥11.3m
Capital spending−CN¥51.4m−CN¥47.4m−CN¥14.2m−CN¥18.2m−CN¥55.2m−CN¥73.0m−CN¥9.5m−CN¥4.1m−CN¥985,425
Free cash flowCN¥66.7mCN¥92.9mCN¥74.3mCN¥73.8mCN¥48.0m−CN¥15.1mCN¥48.3mCN¥18.8mCN¥10.3m
Dividends paid−CN¥32.8m−CN¥42.7m−CN¥31.8m−CN¥36.0m−CN¥30.2m−CN¥330,620−CN¥316,743−CN¥21,647−CN¥20,198

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥97.3mCN¥73.7mCN¥98.5mCN¥80.8mCN¥87.8mCN¥82.5mCN¥81.8mCN¥86.8m
Operating incomeCN¥33.2mCN¥16.3mCN¥26.7mCN¥24.2mCN¥31.6mCN¥29.6mCN¥13.7mCN¥32.9m
Net incomeCN¥28.2mCN¥13.2mCN¥22.1mCN¥21.7mCN¥31.0mCN¥24.0mCN¥11.7mCN¥27.9m
Diluted earnings per share0.360.170.280.270.390.300.150.35
Cash from operations———CN¥24.0mCN¥40.0mCN¥22.0mCN¥31.0mCN¥34.0m
Capital spending−CN¥5.0m−CN¥17.0m−CN¥14.0m−CN¥15.0m−CN¥10.0m−CN¥9.0m−CN¥12.0m−CN¥9.0m
Free cash flow———CN¥9.0mCN¥30.0mCN¥13.0mCN¥19.0mCN¥25.0m
Total assetsCN¥931.7mCN¥918.4mCN¥909.2mCN¥790.9mCN¥778.1mCN¥759.5mCN¥747.2mCN¥737.7m
Cash and short-term investments———CN¥368.0mCN¥388.6mCN¥375.3mCN¥378.5mCN¥377.4m
DebtCN¥42.4mCN¥33.3mCN¥33.9mCN¥37.2m—CN¥37.7m——
Shareholders' equityCN¥745.6mCN¥735.2mCN¥717.8mCN¥688.3mCN¥680.7mCN¥659.3mCN¥635.6mCN¥638.4m

Financial ratios

Data as of 23 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin33.1%33.6%34.1%37.4%45.3%35.8%
Net margin28.3%27.5%27.5%31.5%38.4%31.9%
Return on equity13.8%13.9%12.9%13.9%16.2%21.4%
Return on assets10.9%11.8%11.2%11.9%14.2%18.0%
Free cash flow yield7.7%8.5%4.6%4.8%7.0%7.7%
Revenue growth8.6%17.1%14.6%12.9%29.5%11.0%
Earnings growth11.8%17.1%-0.2%-7.3%55.8%0.9%
Current ratio4.22x4.45x5.35x4.61x6.11x3.79x
Debt to equity0.05x0.06x0.06x0.07x0.04x0.07x
Equity ratio78.9%85.1%86.9%85.1%87.8%83.9%
Interest coverage49.87x46.94x46.32x68.45x108.31x104.03x
R&D as a share of sales7.3%7.4%6.4%7.6%7.9%10.3%
Buybacks as a share of market value0.5%1.1%2.1%-0.8%-33.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.4%16.3%—
Operating income10.3%17.5%—
Net income9.3%13.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings26.525.935.037.247.0
Price to sales7.57.19.611.718.1

Dividends and splits

Per share, in the currency the company pays

Paid for 5 years. Last went ex-dividend on 13 May 2026.

FY2026FY2025FY2024FY2023FY2022FY2021
Paid in the year0.320.380.500.3710.4430.371
  • 7-for-5 split · 27 Apr 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.